Hematology CME

Credits: 0.50 CME
University of Nebraska Medical Center
Exploring Clinical Decisions in the New Era of Myeloma Management: The Impact of Novel Platforms and Agent Classes Across the Spectrum of Care
Luciano Costa, MD, PhD
13 March, 2019
Credits: 0.50 CME
Penn State College of Medicine
Defining the Role of Extended Half-Life Replacement Clotting Factors in the Modern Management of Hemophilia A
Guy Young, MD
25 February, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Building Innovative Treatment Options for Patients With B-Cell Malignancies: Practical Insights on Clinical Evidence and Integration Strategies
Nathan Fowler, MD
15 February, 2019
Credits: 0.50 MOC / CME / CNE / CPE
University of Florida College of Medicine / Medical Learning Institute, Inc.
Turning the Tide on Venous Thromboembolism: Applying Anticoagulation Best Practices to Reduce the Disease Burden
Gregory Piazza, MD, MS
1 February, 2019
Credits: 0.50 CME
Medical Learning Institute, Inc.
Progress in Developing Novel Treatment Options for PTCL: Expert Views on Integrating Innovative Therapeutics Into Care
Younes Anas, MD
29 January, 2019
Credits: 2.00 CME
Medical Learning Institute, Inc.
Exploring the Present and Future of BTK Inhibition in B-Cell Malignancies: Expert Insights on Practical Implications for Patient Management
Andre Goy, MD
21 December, 2018
Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncologist, Nurse, and Patient Partnership in AML: Multiple Perspectives on Integrating Targeted Therapy Into Care
Amir Fathi, MD
5 December, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Improving Patient Outcomes With Cancer Immunotherapies Throughout the Lung Cancer Continuum: State of the Science and Implications for Practice
Edward Garon, MD, MS
22 November, 2018
Credits: 1.50 CME / MOC / CE
Medical Learning Institute, Inc.
Emergency Medicine and Immuno-Oncology Intersect: Recognizing and Managing Cancer Immunotherapy–Related Adverse Effects in the Emergency Department
Daniel Pallin, MD, MPH
21 November, 2018
Credits: 1.00 MOC / CME / CE
Medical Learning Institute, Inc.
Treatment Innovation in Hemophilia A: Integrating Extended Half-Life Replacement Clotting Factors Into Clinical Practice
Mark Reding, MD
6 November, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Integrating BTK Inhibitors Into the Management of B-Cell Malignancies: How Is Evidence Driving Patient Care?
Michael Wang, MD
12 October, 2018
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy in B-Cell Malignancies: An Expert Tumor Board on Novel Agent Classes in CLL, FL, and MCL
Nathan Fowler, MD
9 October, 2018
Credits: 2.00 CME
Penn State College of Medicine
The Arrival of Novel Agent Classes in B-Cell Non-Hodgkin Lymphoma: A Personal Guide to Integrating New Therapy Into Patient Care
John Leonard, MD
5 July, 2018
Credits: 1.50 CME
Penn State College of Medicine
A Personal Look at Innovative Therapy and Meeting Patient Needs in Multiple Myeloma: How I Think, How I Treat
Robert Orlowski, MD, PhD
3 July, 2018
Credits: 2.00 CME
Medical Learning Institute, Inc.
Making Therapeutic Choices for Diverse AML Populations: Exploring New Science, More Effective Treatment Options, and Impact on Patient Care
Farhad Ravandi, MD
3 July, 2018
Credits: 2.00 CME
0 default
Emerging Biomarkers, New Targets, and Rational Combinations: Are We on the Verge of the Next Generation of Immuno-Oncology?
Naiyer Rizvi, MD
18 June, 2018
Credits: 1.00 CME
Medical Learning Institute, Inc.
Reversal of Action: Addressing the Unmet Need for Universal Antidotes to Factor Xa Anticoagulants
Charles Pollack, MA, MD, FACEP, FAAEM, FAHA, FESC, FCPP
12 June, 2018
Credits: 0.50 CME
Medical Learning Institute, Inc.
Treatment Evolution in Newly Diagnosed Hodgkin Lymphoma: A Look at the Evidence and Implications for Practice
Anas Younes, MD
30 May, 2018
Credits: 1.00 CME / CE / CPE
University of Florida College of Medicine
Making the Connection: A Call to Action Against Undiagnosed Atrial Fibrillation—Improving Detection, Reducing Risk
Christian Ruff, MD, MPH
16 May, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Integrated Myeloma Management for Transplant-Eligible Patients: The Conjunction of Novel Therapeutic Platforms, Innovative Agents, and HCT
Paul Richardson, MD
13 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
New Thinking on GVHD Management in HSCT Recipients: Focus on Underlying Immunology and Innovative Therapeutics
David Miklos, MD, PhD
11 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Realizing the Promise of CAR-T Cell Therapy for Leukemia and Lymphoma: Implications for Long-Term Care in the Era of Stem Cell Transplantation
Stephan Grupp, MD, PhD
5 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Refining the Management of CMV in HCT Recipients: What Does the Future Hold?
Francisco Marty, MD
5 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Novel Induction Options in AML: Assessing the Implications for HCT-Eligible Patients
Jorge Cortes, MD
4 April, 2018
Credits: 1.00 CME
The Medical College of Wisconsin
Treatment Innovation in Hodgkin Lymphoma: Integrating New Therapeutic Options With Autologous Transplant Across Clinical Settings
Anas Younes, MD
4 April, 2018